최종보고서 / 2013.12
( 뒷면아래 )
- 2 -
- 3 -
n n Ÿ Ÿ Ÿ Ÿ Ÿ n n - 4 -
n n - 5 -
- 6 -
- 7 -
- 8 -
- 9 -
- 10 -
Ÿ Ÿ Ÿ Ÿ Ÿ - 11 -
Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ - 12 -
α βγ δ - 13 -
- 14 -
Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ - 15 -
- 16 -
- 17 -
Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ - 18 -
- 19 -
Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ - 20 -
Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ - 21 -
- 22 -
α β γ - 23 -
α β γ - 24 -
- 25 -
β γ - 26 -
- 27 -
α β γ Χ Χ Χ Χ - 28 -
- 29 -
- 30 -
- 31 -
α β γ - 32 -
- 33 -
- 34 -
- 35 -
α β γ - 36 -
- 37 -
- 38 -
- 39 -
α β γ - 40 -
- 41 -
- 42 -
- 43 - OH O OH O OH O O OH O OH O OH S O O OH S O O OH S O O OH
- 44 -
( 1 % ) - 45 -
- 46 -
- 47 -
Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ - 48 -
- 49 -
- 50 -
- 51 -
- 52 -
- 53 -
- 54 -
Ÿ Ÿ Ÿ Ÿ Ÿ - 55 -
- 56 -
- 57 -
- 58 -
- 59 -
Ÿ Ÿ Ÿ Ÿ - 60 -
- 61 -
- 62 -
- 63 -
- 64 -
- 65 -
- 66 -
- 67 -
- 68 -
- 69 -
- 70 -
- 71 -
- 72 -
- 73 -
α β γ δ - 74 -
- 75 -
α β γ δ - 76 -
- 77 -
- 78 -
42 ( 1 % ) - 79 -
- 80 -
- 81 -
Ÿ Ÿ Ÿ Ÿ - 82 -
Ÿ Ÿ Ÿ - 83 -
- 84 -
- 85 -
- 86 -
- 87 -
- 88 -
Ÿ Ÿ Ÿ Ÿ - 89 -
- 90 -
- 91 -
- 92 -
- 93 -
- 94 -
- 95 -
- 96 -
α α β β γ γ δ δ - 97 -
α β γ δ - 98 -
α β γ δ - 99 -
- 100 -
- 101 -
- 102 -
- 103 -
- 104 -
- 105 -
α α β β γ γ δ δ - 106 -
- 107 -
RT: 17.65-27.55 100 90 80 70 60 50 40 30 19.77 a-hch? HCH 20.81 21.26?-HCH 22.55 d-hch NL: 3.84E6 m/z= 216.41-217.41 MS ocp_3 α β γ δ 20 10 0 100 90 80 70 17.70 17.95 18.28 18.74 18.93 19.23 19.40 19.62 19.88 20.33 20.45 20.92 21.37 21.70 22.00 22.40 22.66 23.05 23.20 23.59 23.72 23.87 24.18 24.49 24.67 24.99 25.16 25.68 25.79 25.98 19.98 HCB NL: 3.40E6 m/z= 283.31-284.31 MS ocp_3 60 50 40 30 20 10 0 100 90 80 70 60 50 17.71 18.12 18.26 18.80 19.02 19.18 19.50 19.76 20.15 20.35 20.61 20.79 21.29 21.49 21.77 21.98 22.34 22.59 22.87 23.14 23.48 23.72 23.93 24.09 24.58 24.71 25.09 25.20 25.55 25.86 25.97 24.98 Heptachlor NL: 7.09E5 m/z= 271.31-272.31 MS ocp_3 40 30 20 10 0 17.78 18.06 18.49 18.69 19.07 19.32 19.59 19.75 20.09 20.50 20.79 21.00 21.36 21.54 21.85 22.36 22.42 22.72 23.03 23.39 23.62 23.69 24.09 24.34 24.70 25.10 25.39 25.83 25.99 26.39 26.57 26.86 27.10 27.33 27.45 18.0 18.5 19.0 19.5 20.0 20.5 21.0 21.5 22.0 22.5 23.0 23.5 24.0 24.5 25.0 25.5 26.0 26.5 27.0 27.5 Time (min) - 108 -
RT: 23.17-32.43 100 90 80 Aldrin 27.05 NL: 3.34E6 m/z= 262.35-263.35 MS ocp_3 70 60 50 29.29 40 30 20 30.74 31.56 31.71 10 0 100 90 80 26.19 26.40 26.52 26.73 29.56 27.16 27.46 27.64 27.97 28.17 28.40 28.78 28.95 29.69 29.86 30.15 30.31 30.86 31.19 31.84 32.17 29.28 NL: 1.65E5 m/z= 386.30-387.30 MS ocp_3 70 Heptachlor epoxide 60 50 40 30 20 10 0 100 90 80 26.20 26.48 26.72 26.92 27.13 27.29 27.52 27.77 28.00 28.20 28.32 28.71 28.92 29.08 29.41 29.71 29.94 29.30 NL: 7.38E5 m/z= 352.34-353.34 MS ocp_3 70 60 50 Oxychlordane 40 30 20 10 0 26.16 26.39 26.61 26.82 26.95 27.07 27.40 27.61 27.72 28.20 28.32 28.52 28.64 29.11 29.67 29.89 23.5 24.0 24.5 25.0 25.5 26.0 26.5 27.0 27.5 28.0 28.5 29.0 29.5 30.0 30.5 31.0 31.5 32.0 Time (min) 29.56-109 -
RT: 20.88-42.88 100 90 80 30.79 32.82 NL: 1.38E7 m/z= 245.50-246.50 MS ocp_3 70 60 50 40 o,p'-dde 30 20 10 0 100 90 80 70 60 50 40 30.09 30.53 30.90 31.44 32.45 33.28 33.44 30.74 31.55 cis-chlordane trans-chlordane NL: 8.67E5 m/z= 372.32-373.32 MS ocp_3 30 20 10 0 100 90 80 30.42 31.71 30.88 31.98 31.71 35.65 NL: 6.75E5 m/z= 406.28-407.28 MS ocp_3 70 trans-nonachlor 60 50 40 30 20 10 0 30.36 30.73 31.55 31.83 32.40 34.12 34.81 35.78 36.31 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 Time (min) - 110 -
RT: 28.26-40.57 100 90 80 33.28 o,p'-ddd 35.58 NL: 1.41E7 m/z= 234.50-235.50 MS ocp_3 70 60 50 35.77 38.10 40 30 20 10 0 100 90 80 30.79 32.67 32.81 33.47 33.78 33.95 34.58 34.79 35.17 35.88 36.20 36.46 36.89 37.07 37.43 37.65 38.22 38.58 38.86 39.36 39.85 40.14 40.38 32.82 NL: 1.38E7 m/z= 245.50-246.50 MS ocp_3 70 60 50 p,p'-dde 40 30 20 10 0 100 90 80 29.29 30.16 30.53 30.90 31.23 31.52 31.88 32.25 32.45 33.28 33.44 33.73 34.01 35.66 NL: 1.77E6 m/z= 262.35-263.35 MS ocp_3 70 60 50 40 30 20 29.56 30.74 31.56 31.71 Endosulfan I 33.33 Dieldrin 34.70 35.42 Endosulfan II 10 0 28.40 28.78 29.69 29.97 30.31 30.86 31.19 31.84 32.17 32.42 33.06 33.44 33.75 34.25 34.85 35.77 36.36 36.71 36.96 37.33 37.57 37.92 38.10 38.54 39.00 39.17 39.63 39.77 40.27 28.5 29.0 29.5 30.0 30.5 31.0 31.5 32.0 32.5 33.0 33.5 34.0 34.5 35.0 35.5 36.0 36.5 37.0 37.5 38.0 38.5 39.0 39.5 40.0 40.5 Time (min) - 111 -
RT: 29.99-40.56 100 90 80 35.66 NL: 1.77E6 m/z= 262.35-263.35 MS ocp_3 70 60 50 40 30.74 31.56 31.71 33.33 34.70 30 20 Endrin 35.42 10 0 100 90 80 70 60 50 40 30.15 30.31 30.86 31.19 31.84 32.17 32.32 32.60 33.06 33.44 33.75 34.25 34.85 35.77 36.02 36.36 36.71 36.96 37.33 37.57 37.92 38.10 38.54 39.00 39.17 39.63 39.77 40.27 33.28 35.58 p,p'-ddd 35.77 38.10 NL: 1.41E7 m/z= 234.50-235.50 MS ocp_3 30 20 10 0 100 90 80 70 60 50 31.71 o,p'-ddt 32.67 32.81 33.47 33.63 33.95 34.13 34.58 34.79 35.17 35.88 36.20 36.46 36.89 37.07 37.43 37.65 38.22 38.58 38.86 39.07 39.36 39.54 39.85 40.14 40.38 35.65 cis-nonachlor NL: 6.75E5 m/z= 406.28-407.28 MS ocp_3 40 30 20 10 0 30.36 30.54 30.73 30.86 31.55 31.83 32.14 32.40 34.12 34.52 34.81 35.17 35.38 35.78 36.00 36.31 36.51 30.0 30.5 31.0 31.5 32.0 32.5 33.0 33.5 34.0 34.5 35.0 35.5 36.0 36.5 37.0 37.5 38.0 38.5 39.0 39.5 40.0 40.5 Time (min) - 112 -
RT: 34.72-47.01 100 95 90 85 80 75 70 65 60 55 50 45 40 35 30 25 20 15 10 5 34.79 35.17 35.88 36.20 36.46 36.89 37.07 37.43 37.65 38.22 38.58 38.86 39.36 39.85 40.14 40.38 40.95 41.11 41.39 41.68 42.02 42.18 42.52 43.13 43.67 43.81 44.13 44.41 44.85 45.20 45.44 45.80 46.34 46.49 46.99 0 45.41 NL: 100 5.71E6 95 Mirex m/z= 271.31-90 272.31 85 MS ocp_3 80 75 70 65 60 55 50 45 40 35 30 25 20 15 10 35.58 35.77 Endosulfan sulfate 37.10 p,p'-ddt 38.10 5 0 34.88 35.40 35.66 35.85 36.19 36.74 37.43 37.65 37.93 38.21 38.71 38.85 39.52 39.68 39.99 40.48 40.66 41.03 41.31 41.57 42.21 42.46 42.70 43.19 43.34 43.62 44.03 44.28 44.73 44.91 45.55 45.85 46.41 46.62 35.0 35.5 36.0 36.5 37.0 37.5 38.0 38.5 39.0 39.5 40.0 40.5 41.0 41.5 42.0 42.5 43.0 43.5 44.0 44.5 45.0 45.5 46.0 46.5 47.0 Time (min) NL: 1.41E7 m/z= 234.50-235.50 MS ocp_3-113 -
- 114 -
- 115 -
α β γ - 116 -
α β γ - 117 -
- 118 -
β γ - 119 -
δ α β γ δ - 120 -
- 121 -
α β γ - 122 -
- 123 -
α β γ - 124 -
- 125 -
α β γ - 126 -
- 127 -
- 128 -
- 129 -
(disodium methyl arsonate hexahydrate) - 130 -
- 131 -
- 132 -
- 133 -
Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ - 134 -
- 135 -
- 136 -
- 137 -
- 138 -
- 139 -
- 140 -
- 141 -
- 142 -
- 143 -
- 144 -
- 145 -
- 146 -
- 147 -
- 148 -
- 149 -
- 150 -
- 151 -
- 152 -
- 153 -
- 154 -
- 155 -
- 156 -
- 157 -
- 158 -
- 159 -
- 160 -
- 161 -
- 162 -
- 163 -
- 164 -
- 165 -
- 166 -
- 167 -
- 168 -
Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ - 169 -
- 170 -
- 171 -
- 172 -
- 173 -
- 174 -
- 175 -
- 176 -
- 177 -
- 178 -
- 179 -
- 180 -
- 181 -
- 182 -
- 183 -
- 184 -
- 185 -
- 186 -
- 187 -
- 188 -
- 189 -
- 190 -
- 191 -
- 192 -
- 193 -
- 194 -
- 195 -
Ÿ Ÿ Ÿ Ÿ Ÿ - 196 -
Ÿ Ÿ Ÿ - 197 -
- 198 -
- 199 -
- 200 -
- 201 -
- 202 -
- 203 -
- 204 -
- 205 -
- 206 -
- 207 -
- 208 -
- 209 -
- 210 -
- 211 -
- 212 -
- 213 -
- 214 -
- 215 -
- 216 -
HO O OH O OH O NH OH O CH 3 O O NH O OH C H 3 O NH O OH HO O OH O CH 3 ₅ ₅ - 217 -
- 218 -
131 ( 1 % ) - 219 -
- 220 -
- 221 -
Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ Ÿ - 222 -
₅ - 223 -
- 224 -
- 225 -
- 226 -
- 227 -
- 228 -
- 229 -
- 230 -
- 231 -
- 232 -
- 233 -
- 234 -
- 235 -
- 236 -
- 237 -
- 238 -
연구개발목표및세부내용 - 239 -
- 240 -
- 241 -
- 242 -
β ₉ ₈ - 243 -
- 244 -
₉ ₉ ₈ ₈ β - 245 -
- 246 -
- 247 -
- 248 -
- 249 -
- 250 -
Ÿ Ÿ Ÿ Ÿ - 251 -
Ÿ Ÿ Ÿ - 252 -
- 253 -
- 254 -
- 255 -
- 256 -
- 257 -
- 258 -
- 259 -
₈ ₉ - 260 -
- 261 -
- 262 -
- 263 -
- 264 -
- 265 -
- 266 -
- 267 -
- 268 -
- 269 -
- 270 -
- 271 -
fl fl fl - 272 -
- 273 -
- 274 -
- 275 -